Do you want to read an article? Please log in or register.
The implementation of a streamlined TAVI patient pathway across five European countries: BENCHMARK registry
Heart, Artery and Coronary DiseasesTherapy and Intervention
Related content
Atrial Fibrillation
Association of comorbidity patterns with outcomes and relation with the ABC pathway effectiveness in European patients with Atrial Fibrillation
Heart Rhythm
Romiti GF, Corica B, Mei DA, Vitolo M, Bucci T, Bisson A, Fauchier L, Boriani G, Proietti M, Lip GYH
doi: 10.1016/j.hrthm.2025.02.049
Heart Failure
Implementation of guideline-directed medical therapy in patients with heart failure with reduced ejection fraction (OpTIMa-HF Registry)
ESC Heart Fail
Paolillo S, Basile C, Marzano F, Bruzzese D, Agostoni P, Mattavelli I, Aloisio A, Ameri P, Solimano M, Brunetti ND, Calabrò P, Cesaro A, Cameli M, Mandoli GE, Carluccio E, Belardinelli C, Carugo S, Casalino L, Chiuini E, Cosmi D, Dini FL, Di Santo M, Esposito G, Ferrara F, Fierro MF, Galasso G, Gallo L, Rispoli A, Gargiulo P, Grigioni F, Segreti A, Guarnaccia F, Guarnaccia N, Guerra F, Cicchirillo E, Indolfi C, Larcher M, Lillo A, Metra M, Montisci R, Marchetti MF, Nodari S, Fioretti F, Nardi E, Oliviero U, Palazzuoli A, Patti G, Pepe M, Pacelli F, Perrone Filardi F, Putortì G, Santoro G, Senni M, D'Elia E, Severino P, D'Amato A, Soriano S, Sinagra G, Rossi M, Franzese M, Smaldone G, Zito GB, Perrone Filardi P
doi: 10.1002/ehf2.15172
Heart Failure
Eligibility of Asian and European registry patients for phase III trials in heart failure with reduced ejection fraction
ESC Heart Fail
Lim YMF, Asselbergs FW, Bagheri A, Denaxas S, Tay WT, Voors A, Lam CSP, Koudstaal S, Grobbee DE, Vaartjes I
doi: 10.1002/ehf2.14751
RECOMMENDED
Hypertension
Management of patients with hypertension and chronic kidney disease referred to Hypertension Excellence Centres among 27 countries. On behalf of the European Society of Hypertension Working Group on Hypertension and the Kidney
★ 3
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
Blood Press
Halimi JM, Sarafidis P, Azizi M, Bilo G, Burkard T, Bursztyn M, Camafort M, Chapman N, Cottone S, de Backer T, Deinum J, Delmotte P, Dorobantu M, Doumas M, Dusing R, Duly-Bouhanick B, Fauvel JP, Fesler P, Gaciong Z, Gkaliagkousi E, Gordin D, Grassi G, Grassos C, Guerrot D, Huart J, Izzo R, Jaén Águila F, Járai Z, Kahan T, Kantola I, Kociánová E, Limbourg F, Lopez-Sublet M, Mallamaci F, Manolis A, Marketou M, Mayer G, Mazza A, MacIntyre I, Mourad JJ, Muiesan ML, Nasr E, Nilsson P, Oliveras A, Ormezzano O, Paixão-Dias V, Papadakis I, Papadopoulos D, Perl S, Polónia J, Pontremoli R, Pucci G, Robles NR, Rubin S, Ruilope LM, Rump LC, Saeed S, Sanidas E, Sarzani R, Schmieder R, Silhol F, Sokolovic S, Solbu M, Soucek M, Stergiou G, Sudano I, Tabbalat R, Tengiz I, Triantafyllidi H, Tsioufis K, Václavík J, van der Giet M, der Niepen PV, Veglio F, Venzin R, Viigimaa M, Weber T, Widimsky J, Wuerzner G, Zelveian P, Zebekakis P, Lueders S, Persu A, Kreutz R, Vogt L
doi: 10.1080/08037051.2024.2368800
Heart, Artery and Coronary DiseasesTherapy and Intervention
Five-Year Outcomes with Self-expanding versus Balloon-expandable TAVI in Patients with Left Ventricular Systolic Dysfunction
Am Heart J
Nakase M, Tomii D, Maznyczka A, Heg D, Okuno T, Samim D, Stortecky S, Lanz J, Reineke D, Windecker S, Pilgrim T
doi: 10.1016/j.ahj.2024.10.018
Heart Failure
Implementation of guideline-recommended therapies in heart failure with reduced ejection fraction according to heart failure duration: An analysis of 55 581 patients from the Swedish Heart Failure (SwedeHF) Registry
Eur J Heart Fail
Shahim A, Linde C, Savarese G, Dahlström U, Lund LH, Hage C
doi: 10.1002/ejhf.3565
Cardiovascular Risk and Diseases
Definitions of clinical study outcome measures for cardiovascular diseases: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart)
Eur Heart J
Wilkinson C, Bhatty A, Batra G, Aktaa S, Smith AB, Dwight J, Ruciński M, Chappell S, Alfredsson J, Erlinge D, Ferreira J, Guðmundsdóttir IJ, Hrafnkelsdóttir ÞJ, Ingimarsdóttir IJ, Irs A, Jánosi A, Járai Z, Oliveira-Santos M, Popescu BA, Vasko P, Vinereanu D, Yap J, Bugiardini R, Cenko E, Nadarajah R, Sydes MR, James S, Maggioni AP, Wallentin L, Casadei B, Gale CP, Global Cardiovascular Outcomes Consortium and in collaboration with ACNAP, ACVC, EACVI, EAPC, EAPCI, EHRA, ESC Committee for Young CV Professionals, ESC Registry Committee, HFA, ESC Patient Forum and these Working Groups: aorta and peripheral vascular diseases, atherosclerosis and vascular biology, cardiac cellular electrophysiology, cardiovascular pharmacotherapy, cardiovascular regenerative and restorative medicine, cardiovascular surgery, cellular biology of the heart, e-cardiology, myocardial function, pulmonary circulation and right ventricular function and thrombosis
doi: 10.1093/eurheartj/ehae724
Cardiovascular Risk and Diseases
Bempedoic Acid Reduces the Risk of Major Adverse Cardiovascular Events Across Patient Subgroups
Heart Failure
Multiregional Implementation Initiative's Impact on Guideline-Based Performance Measures for Patients Hospitalized With Heart Failure: IMPLEMENT-HF
Circ Heart Fail
Sauer AJ, Beon C, Cherkur S, Mallas-Serdynski L, Thomas K, Spertus J, Chahoud G, Mody KP, Saltzberg MT, Goldberg LR, Lindenfeld J, Sweitzer N, Butler J, Kittleson MM, Pina I, Paul S, Lewis EF, Wald J, Allen LA, Jessup M, Congdon M, Kiser R, Yancy C, Fonarow GC
doi: 10.1161/CIRCHEARTFAILURE.124.012547